Susquehanna International Group
LSTA icon

Susquehanna International Group’s Lisata Therapeutics LSTA Stock Holding History

Susquehanna International Group’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-19,600
Closed -$91K – 13142
2022
Q3 		$91K Buy
19,600
+16,320
+498% +$118K ﹤0.01% 11773
2022
Q2 		$26K Sell
3,280
-660
-17% -$5.43K ﹤0.01% 12283
2022
Q1 		$43K Buy
3,940
+2,220
+129% +$25.4K ﹤0.01% 12372
2021
Q4 		$22K Buy
1,720
+480
+39% +$7.41K ﹤0.01% 12810
2021
Q3 		$23K Sell
1,240
-8,300
-87% -$163K ﹤0.01% 12524
2021
Q2 		$230K Sell
9,540
-1,007
-10% -$23.9K ﹤0.01% 11297
2021
Q1 		$305K Buy
+10,547
New +$320K ﹤0.01% 10567
2020
Q4 		– Sell
-1,300
Closed -$35K – 11434
2020
Q3 		$35K Sell
1,300
-420
-24% -$13.3K ﹤0.01% 10291
2020
Q2 		$46K Buy
+1,720
New +$50.6K ﹤0.01% 9770
2019
Q4 		– Sell
-1,027
Closed -$39K – 10237
2019
Q3 		$39K Sell
1,027
-673
-40% -$26.2K ﹤0.01% 9846
2019
Q2 		$58K Sell
1,700
-267
-14% -$11.9K ﹤0.01% 9806
2019
Q1 		$107K Buy
+1,967
New +$129K ﹤0.01% 8219
2014
Q4 		– Sell
-143
Closed -$119K – 9884
2014
Q3 		$119K Sell
143
-334
-70% -$292K ﹤0.01% 9021
2014
Q2 		$467K Buy
477
+186
+64% +$181K ﹤0.01% 7600
2014
Q1 		$307K Buy
+291
New +$315K ﹤0.01% 7556

Other funds holding LSTA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Susquehanna International Group's LSTA Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Lisata Therapeutics (LSTA) in Q1 2026: 11,604 shares worth $58.1K. The stake represents ﹤0.01% of the portfolio and ranks #12596 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in LSTA as recently as Q3 2024.

Susquehanna International Group first reported a position in LSTA in Q4 2013 and has held it in 23 quarters since. The position peaked at $502K in Q2 2015. 34 funds tracked by Wall St. Rank hold LSTA as of Q1 2026.

  • Susquehanna International Group held 11,604 shares of Lisata Therapeutics worth $58.1K as of Q1 2026.
  • Lisata Therapeutics was a new Susquehanna International Group position in Q1 2026.
  • Lisata Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12596 holding.
  • Susquehanna International Group first reported a position in Lisata Therapeutics in Q4 2013 and has held it in 23 quarters since.
  • Susquehanna International Group's Lisata Therapeutics position peaked at $502K in Q2 2015.
  • 34 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.